European Archives - Page 190 of 1507 - European Medical Journal

Etanercept Improves Cerebrovascular Function in Elderly Rheumatoid Arthritis

A randomized controlled trial shows that the TNF inhibitor etanercept improves cerebral blood flow, vascular reactivity, and endothelial function in elderly patients with rheumatoid arthritis.

Missed and Delayed Bronchiectasis Diagnoses

In this video discussion, leading experts Joseph Khabbaza and Christopher Richards explore the challenges of diagnosing bronchiectasis…

EMJ Respiratory 13 [Supplement 3] 2025

Convened during the European Respiratory Society (ERS) Congress 2025, this symposium provided an in-depth discussion of the identification…

Type 2 Severe Asthma Unplugged

Convened during the European Respiratory Society (ERS) Congress 2025, this symposium provided an in-depth discussion of the…

Atopic Dermatitis in Infants: Why Early Treatment Matters

This webinar discusses the importance of early treatment of atopic dermatitis in paediatric patients, with expert Angela Hernandez…

Tinengotinib Shows Promise in FGFR-Altered Cholangiocarcinoma - EMJ

Tinengotinib Shows Activity in Previously Treated FGFR-Altered Cholangiocarcinoma

A phase 2 trial finds tinengotinib demonstrates anti-tumour activity in previously treated advanced cholangiocarcinoma with FGFR alterations.

Lessons from the Frontlines of Global Health

David Heymann, global health leader and professor of infectious disease epidemiology, shares lessons from Ebola, SARS, smallpox, and the future of pandemic preparedness.

Use of stem cells and growth factors for diabetic foot ulcers

Treating Diabetic Foot Ulcers with Stem Cells and Growth Factors

Review paper concludes that stem cells and growth factors are effective in treating diabetic foot ulcers. But improved treatment protocols are needed before wider clinical adoption.

Do Magnesium Supplements Show Arrhythmia Benefit? - EMJ

Do Magnesium Supplements Protect Against Tachyarrhythmias?

Discover how magnesium supplements showed no measurable arrhythmia benefit in a major ICU study using causal methods.

SLE Linked to Reduced ICU Survival Through Renal Dysfunction

Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, with glucocorticoids potentially mitigating mortality risk.